This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Enteric coated aspirin - does this reduce risk of bleeding complications?

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • there is no evidence that using enteric coated or buffered formulations of aspirin provide less of a risk than the use of dispersible aspirin 75mg, which is an appropriate dosage form

Reference:

  1. MeReC Bulletin 2005; 15(6):21-4.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.